Corvus Pharmaceuticals CRVS Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's total current assets?
- Corvus Pharmaceuticals (CRVS) reported total current assets of $239.95M in Q1 2026.
- How has Corvus Pharmaceuticals's total current assets changed year-over-year?
- Corvus Pharmaceuticals's total current assets increased by 427.5% year-over-year, from $45.49M to $239.95M.
- What is the long-term trend for Corvus Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's total current assets has grown at a 5.1% compound annual growth rate (CAGR), from $45.34M to $58.21M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.